Aktualności
EMA: Guideline on core SmPC and Package Leaflet for Radiopharmaceuticals
04.10.2011
This guideline describes the information to be included in the Summary of Products Characteristics (SmPC) and Package Leaflet for Radiopharmaceuticals. ...
EMA: Guideline on quality of herbal medicinal products/traditional herbal medicinal products
04.10.2011
This guideline intends to cover the general quality aspects of herbal medicinal products (for human and veterinary use), including traditional herbal medicinal products for human use.
The special
...
EMA: Reflection Paper on risk based Quality Management in Clinical Trials
04.10.2011
The purpose of this reflection paper is to facilitate the development of a more systematic, prioritised, risk-based approach to quality management of clinical trials, to support the principles of
...
FDA: Time and Extent Applications for Nonprescription Drug Products
04.10.2011
This guidance is intended to explain what information an applicant should submit to the Food and Drug Administration (FDA) to request that a drug product be included in the over-the¬counter (OTC)
...
FDA: Self-Selection Studies for Nonprescription Drug Products
22.09.2011
This guidance is intended to provide recommendations to industry involved in developing and conducting self-selection studies to support an application for nonprescription drug products. A
...
GMP: EMA publishes two advisory Documents addressing a Number of Questions about centralised Admission Procedures
22.09.2011
The EMA has recently published two documents concerning the centralised application procedures for new, generic and hybrid medicinal products.
In the Q&A section on its website the European
...
TOPRA: EU Module 1 v1.4.1 Specification
22.09.2011
This document specifies Module 1 of the electronic Common Technical Document (eCTD) for the European Union (“EU”). ...
EMA: Periodic Signal Detection for Centrally Authorised Products Based on Reaction Monitoring Reports
22.09.2011
To describe the process by which identification of new safety signals for Centrally Authorised medicinal Products (CAPs) is conducted periodically in the Pharmacovigilance and Risk Management
...
GMP: Faster Sterility Tests for Biological Products
15.09.2011
The FDA Center for Biologics Evaluation and Research (CBER) in Rockville, MD, published a poster that considers rapid sterility testing and compares different modern methods with compendial methods. ...
EMA: Concept paper on pharmacovigilance implementing measures released for consultation
15.09.2011
The European Commission is seeking views from the public on a concept paper on implementing measures for the performance of activities related to the safety monitoring of medicines. ...
